Intrinsic value of Dolby Laboratories Cl A - DLB

Previous Close

$68.08

  Intrinsic Value

$48.19

stock screener

  Rating & Target

sell

-29%

Previous close

$68.08

 
Intrinsic value

$48.19

 
Up/down potential

-29%

 
Rating

sell

We calculate the intrinsic value of DLB stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 4.4

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  3.90
  4.01
  4.11
  4.20
  4.28
  4.35
  4.42
  4.47
  4.53
  4.57
  4.62
  4.65
  4.69
  4.72
  4.75
  4.77
  4.80
  4.82
  4.83
  4.85
  4.87
  4.88
  4.89
  4.90
  4.91
  4.92
  4.93
  4.94
  4.94
  4.95
Revenue, $m
  1,124
  1,169
  1,217
  1,268
  1,322
  1,380
  1,440
  1,505
  1,573
  1,645
  1,721
  1,801
  1,885
  1,974
  2,068
  2,167
  2,271
  2,380
  2,495
  2,616
  2,744
  2,878
  3,018
  3,166
  3,322
  3,485
  3,657
  3,838
  4,027
  4,227
Variable operating expenses, $m
  789
  819
  850
  884
  920
  957
  997
  1,040
  1,085
  1,132
  1,132
  1,185
  1,240
  1,299
  1,360
  1,425
  1,494
  1,565
  1,641
  1,721
  1,805
  1,893
  1,985
  2,082
  2,185
  2,292
  2,405
  2,524
  2,649
  2,780
Fixed operating expenses, $m
  76
  77
  79
  81
  83
  84
  86
  88
  90
  92
  94
  96
  98
  100
  103
  105
  107
  109
  112
  114
  117
  119
  122
  125
  127
  130
  133
  136
  139
  142
Total operating expenses, $m
  865
  896
  929
  965
  1,003
  1,041
  1,083
  1,128
  1,175
  1,224
  1,226
  1,281
  1,338
  1,399
  1,463
  1,530
  1,601
  1,674
  1,753
  1,835
  1,922
  2,012
  2,107
  2,207
  2,312
  2,422
  2,538
  2,660
  2,788
  2,922
Operating income, $m
  259
  273
  287
  303
  320
  338
  357
  377
  398
  421
  495
  520
  547
  576
  605
  637
  670
  705
  742
  781
  822
  866
  911
  959
  1,010
  1,063
  1,119
  1,178
  1,239
  1,305
EBITDA, $m
  374
  390
  407
  426
  446
  467
  490
  514
  539
  566
  594
  624
  656
  689
  724
  762
  801
  842
  886
  932
  980
  1,031
  1,085
  1,141
  1,201
  1,263
  1,329
  1,398
  1,471
  1,548
Interest expense (income), $m
  0
  0
  1
  2
  3
  4
  5
  6
  7
  8
  10
  11
  13
  14
  16
  18
  20
  21
  24
  26
  28
  30
  33
  36
  38
  41
  44
  48
  51
  55
  58
Earnings before tax, $m
  259
  272
  286
  300
  316
  333
  351
  370
  390
  411
  484
  508
  533
  560
  588
  617
  649
  682
  717
  753
  792
  833
  876
  921
  968
  1,018
  1,071
  1,127
  1,185
  1,246
Tax expense, $m
  70
  73
  77
  81
  85
  90
  95
  100
  105
  111
  131
  137
  144
  151
  159
  167
  175
  184
  193
  203
  214
  225
  236
  249
  261
  275
  289
  304
  320
  337
Net income, $m
  189
  198
  209
  219
  231
  243
  256
  270
  285
  300
  353
  371
  389
  409
  429
  451
  474
  498
  523
  550
  578
  608
  639
  672
  707
  743
  782
  822
  865
  910

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  1,971
  2,050
  2,135
  2,224
  2,319
  2,420
  2,527
  2,640
  2,760
  2,886
  3,019
  3,160
  3,308
  3,464
  3,628
  3,802
  3,984
  4,176
  4,378
  4,590
  4,814
  5,048
  5,295
  5,555
  5,828
  6,115
  6,416
  6,733
  7,065
  7,415
Adjusted assets (=assets-cash), $m
  1,971
  2,050
  2,135
  2,224
  2,319
  2,420
  2,527
  2,640
  2,760
  2,886
  3,019
  3,160
  3,308
  3,464
  3,628
  3,802
  3,984
  4,176
  4,378
  4,590
  4,814
  5,048
  5,295
  5,555
  5,828
  6,115
  6,416
  6,733
  7,065
  7,415
Revenue / Adjusted assets
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
  0.570
Average production assets, $m
  749
  780
  812
  846
  882
  920
  961
  1,004
  1,049
  1,097
  1,148
  1,201
  1,258
  1,317
  1,380
  1,445
  1,515
  1,588
  1,664
  1,745
  1,830
  1,919
  2,013
  2,112
  2,216
  2,325
  2,439
  2,560
  2,686
  2,819
Working capital, $m
  -121
  -126
  -131
  -137
  -143
  -149
  -156
  -163
  -170
  -178
  -186
  -195
  -204
  -213
  -223
  -234
  -245
  -257
  -269
  -283
  -296
  -311
  -326
  -342
  -359
  -376
  -395
  -414
  -435
  -456
Total debt, $m
  15
  32
  49
  68
  88
  109
  131
  155
  180
  206
  234
  264
  295
  327
  362
  398
  436
  476
  518
  563
  609
  658
  710
  764
  821
  881
  944
  1,010
  1,080
  1,153
Total liabilities, $m
  412
  429
  446
  465
  485
  506
  528
  552
  577
  603
  631
  660
  691
  724
  758
  795
  833
  873
  915
  959
  1,006
  1,055
  1,107
  1,161
  1,218
  1,278
  1,341
  1,407
  1,477
  1,550
Total equity, $m
  1,559
  1,622
  1,688
  1,759
  1,835
  1,914
  1,999
  2,088
  2,183
  2,283
  2,388
  2,499
  2,616
  2,740
  2,870
  3,007
  3,151
  3,303
  3,463
  3,631
  3,808
  3,993
  4,189
  4,394
  4,610
  4,837
  5,075
  5,326
  5,589
  5,865
Total liabilities and equity, $m
  1,971
  2,051
  2,134
  2,224
  2,320
  2,420
  2,527
  2,640
  2,760
  2,886
  3,019
  3,159
  3,307
  3,464
  3,628
  3,802
  3,984
  4,176
  4,378
  4,590
  4,814
  5,048
  5,296
  5,555
  5,828
  6,115
  6,416
  6,733
  7,066
  7,415
Debt-to-equity ratio
  0.010
  0.020
  0.030
  0.040
  0.050
  0.060
  0.070
  0.070
  0.080
  0.090
  0.100
  0.110
  0.110
  0.120
  0.130
  0.130
  0.140
  0.140
  0.150
  0.150
  0.160
  0.160
  0.170
  0.170
  0.180
  0.180
  0.190
  0.190
  0.190
  0.200
Adjusted equity ratio
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791
  0.791

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  189
  198
  209
  219
  231
  243
  256
  270
  285
  300
  353
  371
  389
  409
  429
  451
  474
  498
  523
  550
  578
  608
  639
  672
  707
  743
  782
  822
  865
  910
Depreciation, amort., depletion, $m
  115
  117
  120
  123
  126
  129
  133
  137
  141
  145
  99
  104
  108
  114
  119
  125
  131
  137
  143
  150
  158
  165
  174
  182
  191
  200
  210
  221
  232
  243
Funds from operations, $m
  304
  316
  329
  342
  357
  373
  389
  407
  425
  445
  452
  474
  497
  522
  548
  575
  604
  635
  667
  700
  736
  773
  813
  854
  898
  944
  992
  1,043
  1,097
  1,153
Change in working capital, $m
  -5
  -5
  -5
  -6
  -6
  -6
  -7
  -7
  -7
  -8
  -8
  -9
  -9
  -10
  -10
  -11
  -11
  -12
  -12
  -13
  -14
  -14
  -15
  -16
  -17
  -18
  -19
  -19
  -20
  -22
Cash from operations, $m
  308
  321
  334
  348
  363
  379
  396
  414
  433
  453
  460
  483
  507
  532
  558
  586
  615
  646
  679
  713
  750
  788
  828
  870
  915
  961
  1,011
  1,063
  1,117
  1,174
Maintenance CAPEX, $m
  -62
  -65
  -67
  -70
  -73
  -76
  -79
  -83
  -87
  -90
  -95
  -99
  -104
  -108
  -114
  -119
  -125
  -131
  -137
  -143
  -150
  -158
  -165
  -174
  -182
  -191
  -200
  -210
  -221
  -232
New CAPEX, $m
  -29
  -30
  -32
  -34
  -36
  -38
  -41
  -43
  -45
  -48
  -51
  -53
  -56
  -59
  -63
  -66
  -69
  -73
  -77
  -81
  -85
  -89
  -94
  -99
  -104
  -109
  -115
  -120
  -127
  -133
Cash from investing activities, $m
  -91
  -95
  -99
  -104
  -109
  -114
  -120
  -126
  -132
  -138
  -146
  -152
  -160
  -167
  -177
  -185
  -194
  -204
  -214
  -224
  -235
  -247
  -259
  -273
  -286
  -300
  -315
  -330
  -348
  -365
Free cash flow, $m
  218
  226
  235
  244
  254
  264
  276
  288
  301
  314
  315
  330
  347
  364
  382
  401
  421
  443
  465
  489
  514
  541
  569
  598
  629
  661
  696
  732
  770
  810
Issuance/(repayment) of debt, $m
  15
  17
  18
  19
  20
  21
  22
  24
  25
  26
  28
  29
  31
  33
  34
  36
  38
  40
  42
  44
  47
  49
  52
  54
  57
  60
  63
  66
  70
  73
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  15
  17
  18
  19
  20
  21
  22
  24
  25
  26
  28
  29
  31
  33
  34
  36
  38
  40
  42
  44
  47
  49
  52
  54
  57
  60
  63
  66
  70
  73
Total cash flow (excl. dividends), $m
  233
  242
  252
  263
  274
  285
  298
  311
  326
  341
  343
  360
  378
  397
  416
  437
  460
  483
  508
  534
  561
  590
  620
  652
  686
  721
  759
  798
  839
  883
Retained Cash Flow (-), $m
  -59
  -63
  -67
  -71
  -75
  -80
  -85
  -89
  -95
  -100
  -105
  -111
  -117
  -124
  -130
  -137
  -144
  -152
  -160
  -168
  -177
  -186
  -195
  -205
  -216
  -227
  -238
  -251
  -263
  -277
Prev. year cash balance distribution, $m
  636
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  810
  180
  186
  192
  198
  206
  214
  222
  231
  241
  238
  249
  260
  273
  286
  300
  315
  331
  348
  366
  384
  404
  425
  447
  470
  495
  520
  548
  576
  606
Discount rate, %
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
  777
  165
  161
  158
  154
  149
  144
  139
  133
  126
  113
  106
  99
  92
  84
  76
  69
  61
  54
  46
  40
  34
  28
  23
  18
  14
  11
  8
  6
  5
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Dolby Laboratories, Inc. designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration. Its technologies include Advanced Audio Coding and High Efficiency Advanced Audio Coding, Dolby AC-4, Dolby Atmos, Dolby Digital, Dolby Digital Plus, Dolby TrueHD, Dolby Vision, Dolby Voice and High Efficiency Video Coding. It distributes its products in over 80 countries. Its technologies are incorporated in offerings in various end markets, such as the broadcast, Personal Computer, mobile, consumer electronics and other markets.

FINANCIAL RATIOS  of  Dolby Laboratories Cl A (DLB)

Valuation Ratios
P/E Ratio 34.4
Price to Sales 6.4
Price to Book 3.3
Price to Tangible Book
Price to Cash Flow 18.7
Price to Free Cash Flow 26.1
Growth Rates
Sales Growth Rate 5.4%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -52.7%
Cap. Spend. - 3 Yr. Gr. Rate -2.1%
Financial Strength
Quick Ratio NaN
Current Ratio 0.1
LT Debt to Equity 0%
Total Debt to Equity 0%
Interest Coverage 0
Management Effectiveness
Return On Assets 8.3%
Ret/ On Assets - 3 Yr. Avg. 8.5%
Return On Total Capital 9.8%
Ret/ On T. Cap. - 3 Yr. Avg. 10%
Return On Equity 9.8%
Return On Equity - 3 Yr. Avg. 10%
Asset Turnover 0.4
Profitability Ratios
Gross Margin 89.1%
Gross Margin - 3 Yr. Avg. 89.6%
EBITDA Margin 31.5%
EBITDA Margin - 3 Yr. Avg. 31.8%
Operating Margin 22.9%
Oper. Margin - 3 Yr. Avg. 22.5%
Pre-Tax Margin 23.8%
Pre-Tax Margin - 3 Yr. Avg. 24%
Net Profit Margin 18.7%
Net Profit Margin - 3 Yr. Avg. 18.5%
Effective Tax Rate 21.4%
Eff/ Tax Rate - 3 Yr. Avg. 22.7%
Payout Ratio 28.2%

DLB stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the DLB stock intrinsic value calculation we used $1081.454 million for the last fiscal year's total revenue generated by Dolby Laboratories Cl A. The default revenue input number comes from 0001 income statement of Dolby Laboratories Cl A. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our DLB stock valuation model: a) initial revenue growth rate of 3.9% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for DLB is calculated based on our internal credit rating of Dolby Laboratories Cl A, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Dolby Laboratories Cl A.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of DLB stock the variable cost ratio is equal to 70.4%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $74 million in the base year in the intrinsic value calculation for DLB stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Dolby Laboratories Cl A.

Corporate tax rate of 27% is the nominal tax rate for Dolby Laboratories Cl A. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the DLB stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for DLB are equal to 66.7%.

Life of production assets of 11.6 years is the average useful life of capital assets used in Dolby Laboratories Cl A operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for DLB is equal to -10.8%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $2136.742 million for Dolby Laboratories Cl A - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 64.364 million for Dolby Laboratories Cl A is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Dolby Laboratories Cl A at the current share price and the inputted number of shares is $4.4 billion.

RELATED COMPANIES Price Int.Val. Rating
SSTK Shutterstock 38.14 41.14  hold
SNE Sony ADR 51.14 3,771.76  str.buy

COMPANY NEWS

▶ Binge Smarter with Dolby Dimension   [Nov-14-18 08:30AM  GlobeNewswire]
▶ Dolby Laboratories: Fiscal 4Q Earnings Snapshot   [04:49PM  Associated Press]
▶ This New Device Could Help Amazon Catch Up to Roku   [Oct-20-18 08:00PM  Motley Fool]
▶ Kissing MoviePass Goodbye Never Felt So Right   [Oct-14-18 03:13PM  Motley Fool]
▶ $20 million gift focuses UCSF on depression, mood disorders   [10:31AM  American City Business Journals]
▶ Dolby Laboratories, Inc. Smashes Another Earnings Target   [Jul-26-18 09:51AM  Motley Fool]
▶ Dolby Laboratories: Fiscal 3Q Earnings Snapshot   [04:51PM  Associated Press]
▶ Dolby Laboratories Earnings Outlook   [09:03AM  Benzinga]
▶ Dolby and Cinescape to Bring First Dolby Cinemas to Kuwait   [Jul-24-18 08:30AM  GlobeNewswire]
▶ Dolby Laboratories Celebrates Pride Around the World   [Jun-25-18 04:05PM  GlobeNewswire]
▶ Dolby Cinema at AMC Opens Its 100th Location   [08:36AM  GlobeNewswire]
▶ Dolby stock falls after weak outlook   [Apr-24-18 04:41PM  MarketWatch]
▶ Dolby Laboratories: Fiscal 2Q Earnings Snapshot   [04:37PM  Associated Press]
▶ Dolby and Disney Announce Extended Theatrical Collaboration   [Apr-19-18 08:30AM  GlobeNewswire]
▶ Dolby Laboratories Celebrates International Womens Day 2018   [Mar-08-18 07:35PM  GlobeNewswire]
▶ 5 Things Dolby Laboratories Management Wants You to Know   [Jan-27-18 11:00AM  Motley Fool]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.